UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Cardiac amyloidosis

Martinez-Naharro, A; Hawkins, PN; Fontana, M; (2018) Cardiac amyloidosis. Clinical Medicine , 18 (Suppl 2) s30-s35. 10.7861/clinmedicine.18-2-s30.

[img] Text
Martinez-Naharro_Cardiac_amyloidosis.pdf - ["content_typename_Published version" not defined]
Access restricted to UCL open access staff until 1 April 2019.

Download (7MB)


Systemic amyloidosis comprises an uncommon group of disorders caused by the extracellular deposition of misfolded proteins in various organs. Cardiac amyloid deposition, causing an infiltrative/restrictive cardiomyopathy, is a frequent feature of amyloidosis and a major determinant of survival. It may be the presenting feature of the disease or may be identified while investigating a patient presenting with other organ involvement. The need for a high index of suspicion and the critical importance of precise biochemical typing of the amyloid deposits is paramount in light of recent therapeutic advances that can significantly improve prognosis. Most cases of cardiac amyloidosis are of either transthyretin type, which may be acquired in older individuals or inherited in younger patients, or acquired monoclonal immunoglobulin light chain (AL) type. This article aims to review recent developments in diagnosis and management of cardiac amyloidosis.

Type: Article
Title: Cardiac amyloidosis
Location: England
DOI: 10.7861/clinmedicine.18-2-s30
Publisher version: http://doi.org/10.7861/clinmedicine.18-2-s30
Language: English
Additional information: This is the published version of record. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: AL amyloidosis, ATTR amyloidosis, CMR, cardiac amyloidosis, infiltrative cardiomyopathy
URI: http://discovery.ucl.ac.uk/id/eprint/10048587
Downloads since deposit
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item